Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2010
12/14/2010CA2553293C Sulfonamide derivatives for the treatment of diseases
12/14/2010CA2478858C Catalysts and method for the production of amines
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010WO2010139827A1 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
12/09/2010US20100311973 Method for producing amines from sugar alcohols
12/09/2010US20100311754 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
12/09/2010US20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010CA2764214A1 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258706A2 Functionalized ionic liquids, and methods of use thereof
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
12/08/2010EP2258681A2 Aromatic Derivatives as HIV Aspartyl Protease Inhibitors
12/08/2010EP2258680A2 Aromatic derivatives as HIV aspartyl protease inhibitors
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP2257515A1 1,4-naphthoquinone derivatives and therapeutic use thereof
12/08/2010CN101906085A Compound and composition for treating cardiovascular and cerebrovascular diseases and preparation method and use thereof
12/08/2010CN101906084A Preparation method of piperazine and own derivatives
12/08/2010CN101307038B 4- benzyl piperazi ethyliminumacyl (formimidoyl benzol)hydrazine compounds, preparation method thereof, pharmaceutical compositions and use
12/08/2010CN101128446B Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
12/08/2010CN101068791B Method for preparing salt with tetrafluoroborate anion and reducing the content of hologenate
12/08/2010CN101039928B Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid
12/08/2010CN101012170B N-arylation method in water solution
12/07/2010US7847096 pyrimidine- or pyridinecarboxylic acid derivatives which are substituted in the 2- or 4-position by an optionally substituted 4-(3-oxomorpholin-4-yl)aniline radical, such as 6-methyl-2-[4-(3-oxomorpholin-4-yl)phenylamino]nicotinic acid, suitable for the treatment of viral diseases, such as hepatitis C
12/07/2010US7846963 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/07/2010CA2446326C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305090 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
12/02/2010US20100305056 Cysteine protease inhibitors for the treatment of parasitic disease
12/01/2010EP2256109A1 Apoptosis inhibitor
12/01/2010CN101903347A Piperidinyl and piperazinyl modulators of gamma-secretase
12/01/2010CN101903332A 4-hydroxyphenylalkylamine derivative
12/01/2010CN101903097A Method for the production of an amine
12/01/2010CN101903096A Method for the production of an amine
12/01/2010CN101903095A Method for producing an amine
12/01/2010CN101903094A Method for producing an amine
12/01/2010CN101903093A Method for producing an amine
12/01/2010CN101903092A Method for producing an amine
12/01/2010CN101899003A Quinoline derivative-N-oxide ligand as well as preparation method and application thereof
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101898966A Bromine and piperazine ring-containing Artemisia rupestris L. keto ester derivative as well as preparation method and application thereof
12/01/2010CN101633647B Method for synthesizing alpha-azyl aryl alkyl ketone compound with high selectivity and high yield
11/2010
11/30/2010US7842804 Ionic salts comprising pyrrolidinium, triazolinium, piperidinium or morpholinium cations and alkyltrifluorophosphate anions
11/30/2010US7842729 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections
11/30/2010US7842707 Peptidase inhibitors
11/30/2010US7842705 Curcumin analogs with anti-tumor and anti-angiogenic properties
11/30/2010US7842696 such as 4-Benzenesulfinyl-N-{2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-benzamide, used for the treatment of syndrome X, obesity, insulin resistance, dyslipidemia and cardiovascular diseases
11/30/2010CA2460682C Ester compound and medical use thereof
11/25/2010US20100298561 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
11/25/2010US20100298442 1-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
11/25/2010US20100298368 Antagonists of pgd2 receptors
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298328 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes
11/25/2010US20100298323 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/25/2010US20100298299 non-peptide derivatives as bradykinin b1 antagonists
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/25/2010US20100297240 1- [2- (2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
11/24/2010EP2253618A1 Compound having 6-membered aromatic ring
11/24/2010EP2253615A1 Cyclopropyl amide derivatives
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252583A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN101896459A Anthelmintic agents and their use
11/24/2010CN101891707A Method for preparing Quetiapine or pharmaceutically acceptable fumarate thereof
11/24/2010CN101891654A Low molecular weight quaternary ammonium salt dispersants
11/24/2010CN101235019B 3,5-diiodo salicylaldehyde-4-(omega-aminoalkyl)morpholine metal complexes, preparation method and use thereof
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010CA2584789C Method for the preparation of aripiprazole, and corresponding intermediates and their preparation
11/23/2010CA2434775C Compounds for use in the treatment of skin conditions
11/18/2010WO2010131717A1 Prion protein structure transformation inhibitor and utilization of same
11/18/2010WO2010130260A2 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292472 Prophylactic and therapeutic medicine for malaria
11/18/2010US20100292467 Low molecular weight quaternary ammonium salt dispersants
11/18/2010US20100291003 Histone deacetylase inhibitors
11/18/2010CA2761383A1 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
11/18/2010CA2703444A1 Low molecular weight quaternary ammonium salt dispersants
11/17/2010EP2251334A1 Labeling reagents and labeled analytes
11/17/2010CN101888989A Novel aryl potassium channel blockers and uses thereof
11/17/2010CN101239957B Method for synthesizing N-methylpiperazine
11/16/2010US7834197 such as N-methyl-N-methoxymethylpyrrolidinium chloride; high solubility in organic solvents, high voltage resistance and high electrical conductivity
11/16/2010US7834062 Aminoalkylphenols, methods of using and making the same
11/16/2010US7834047 Arylsulfonamides and uses related thereto
11/16/2010US7834018 Aminopyridine derivatives having aurora a selective inhibitory action
11/16/2010US7834017 Melanocortin receptor modulators; sexual disorders, obesity, cachexia, eating disorders; for example 1,4-bis(2-amino-3-p-tolyl-propionyl)-2-isobutyl-5-(4-(2-aminoethylamino)butyl)piperazine
11/16/2010US7834013 Racemic-(trans)-2-[4-({[3-(phenyloxy)phenyl]methyl}ammonium)phenyl]cyclopropanecarboxylic acid; type II diabetes; G protein-coupled receptor 40 (GPR40) agonists
11/16/2010US7834012 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
11/16/2010US7834008 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
11/11/2010WO2010129379A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286073 Compounds and methods for pharmaceutical use
11/11/2010CA2761241A1 Tetracycline compounds
11/11/2010CA2759399A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/10/2010EP2248901A1 Streptogramines and method for preparing same by mutasynthesis
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 341